| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |